Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Hantz Group employs a holistic approach to provide clients with comprehensive financial, estate, and tax planning solutions.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
John Hantz - Chief Executive Officer - Hantz Holdings llc
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
PT Solusi Tunas Pratama Tbk plans to increase its tower count from 1,000 in 2014 to 39,000.
00:10:00
Watch our new free webinar to learn about Qualified Electronic Registered Delivery Services (SERCQ) and whether they can replace PEC, explained by Sabrina Dondi, Head of Competence Center at Doxee.|Sergio Muratori Casali is Founder & Co-CEO of Doxee SpA
00:10:00
"Navigating Financial Stability: Insights from PFM Asset Management LLC | City of Winter Springs Presentation, March 11, 2024"
00:10:00
Insights from Rajitha Kariyawasan: Hayleys Group MD on Leadership and Six Sigma Excellence|RAJITHA KARIYAWASAN,Managing Director,Haycarb Plc
00:10:00
Executive Shares Insights on Industry Trends and Adaptations Amidst Market Changes | Salvador Rodriguez, CEO, CI Banco SA Institucion de Banca Multiple.
00:00:00
ReNeuron focus on new clinical trials - Michael Hunt, Chief Financial Officer, ReNeuron Group
00:10:00
Highlights from Virtual STAR Conference Spring Edition 2021 | Nazareno Ventola - CEO of aeroporto guglielmo marconi di bologna s.p.a
00:10:00
Investment in digital bank Revolut, valued at $25.7 billion|Martin Mignot,investor,Index Ventures
00:10:00
Surviving Wall Street: James Gorman on Innovation and Adaptation at Morgan Stanley
00:00:00
Imugene sees positive early signals in Phase 1 VAXINIA study - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:10:00
George Peristeris: Pioneering Pathways in Terna Energy |George Peristeris, Chairman, Terna Energy SA.
00:10:00
Leading with Soul: Insights from André Lacroix, CEO of Intertek Group | André Lacroix - Chief Executive Officer of Intertek Group plc